Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

Heparin-induced thrombocytopenia is a serious complication of heparin therapy that can lead to thromboembolism, cardiovascular events, and death. Hemodialysis patients are repeatedly exposed to heparin and are at risk for developing antibodies to the platelet factor 4-heparin (PF4-H) complex. We sou...

Ausführliche Beschreibung